Clinical Trials Browser

Phase 2/3 × Lung Neoplasms × Docetaxel × Clear all

NCT05096663 2025-05-15

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01348126 2015-11-05

GALAXY

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00030641 2014-01-06

Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms